Mark L. Smythe
Chief Executive Officer bei Infensa Bioscience Pty Ltd.
Profil
Mark L.
Smythe is the founder of Protagonist Therapeutics, Inc. which was founded in 2006.
He held the title of Vice President-Technology from 2013 to 2022.
Currently, he is the Chief Executive Officer at Infensa Bioscience Pty Ltd.
since 2022.
He previously worked at GSK Plc as a Principal.
Dr. Smythe obtained a doctorate from the University of Melbourne and an undergraduate degree from James Cook University.
Aktive Positionen von Mark L. Smythe
| Unternehmen | Position | Beginn |
|---|---|---|
| Infensa Bioscience Pty Ltd. | Chief Executive Officer | 01.05.2022 |
Ehemalige bekannte Positionen von Mark L. Smythe
| Unternehmen | Position | Ende |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Founder | 01.05.2022 |
| GSK PLC | Corporate Officer/Principal | - |
Ausbildung von Mark L. Smythe
| University of Melbourne | Doctorate Degree |
| James Cook University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
| Infensa Bioscience Pty Ltd. |
